Melissa Hanna is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.
Melissa Hanna, J.D., MBA, co-founder and CEO of Mahmee in Los Angeles
I grew up in California’s San Fernando Valley and earned a B.A. in public policy and sociology at Pomona College, an MBA at Claremont Graduate University and a J.D. at Southwestern University School of Law.
Career highlights include securing an all-star lineup of investors in our seed fundraising, including Serena Williams and Mark Cuban, and establishing a first-of-its-kind public-private partnership with the DC Department of Health to serve new and expecting mothers in Washington, D.C.
Who has had the greatest influence on your life?
My mother, Linda Hanna, M.S.N./Ed., RNC, who is Mahmee’s other co-founder and whose work inspired its formation in 2014. As someone who delivers maternal and infant healthcare and also trains healthcare providers, my mother set an example of how integrated models of care could work at scale and where technology could make the greatest impact in this industry.
Why did you pursue a career in healthcare?
I did not initially decide to pursue a career in healthcare. Instead, I started my career in education, with a focus on policy and technology. After graduating from college, I worked for some educational tech startups. What I learned in those spaces about centering a student’s experience and needs in school informed my views on healthcare and led me to wonder where else these lessons could be applied. Centering maternity patients’ experiences and needs in healthcare was an exciting prospect for me despite the field’s known complexities.
Which career accomplishment has given you the greatest satisfaction?
Leading my current team at Mahmee. As Mahmee continues to grow, I take pride in sharing my passion for this work with new employees and leading them to find more effective ways to support patients and providers in maternal and infant health. Furthermore, I find myself in new and greater learning opportunities as I work toward improving my own skills as a strategic leader, which is incredibly satisfying.
What has your organization’s role been in the rollout of COVID-19 vaccines?
Earlier this year, we mandated that all 30 of Mahmee’s employees be fully vaccinated, which we achieved last spring. Because all types of expectant and new parents and providers use Mahmee, we have a unique reach into some of the most at-risk U.S. communities. Since the vaccine rollout began, Mahmee has promoted vaccinations among pregnant and postpartum mothers and continues to provide updated information on risks and considerations for birthing individuals based on guidelines and recommendations by local and federal public health officials.
What would be the best way to reduce healthcare inequities in the U.S.?
According to the CDC, (approximately) 700 pregnant women die during pregnancy or in the first postpartum year, and 50,000 women become injured or experience serious complications.
What’s more, Black women are three times more likely to die from a pregnancy-related cause than White women, and in many cities pregnancy-related risk is disproportionately concentrated in certain areas.
The healthcare industry lacks the information technology infrastructure needed to connect professionals from different organizations to discuss cases and to follow and monitor patients across practices and health systems. This missing element creates serious gaps in care.
By zeroing in on these gaps and closing them, I believe we will make a massive impact on maternal health complications within the U.S.
Name a book or article that everyone in healthcare should read.
“Upstream: The Quest to Solve Problems Before They Happen,” by Dan Heath. The book delves into how to prevent or solve problems before they occur, which is a critical skill when running a business.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More